Given the findings that HR-DNA repair proteins (BRCA1, BRCA2 and RAD51) are significantly increased in TMZ-resistant glioma cells, an abundance expression of BRCC3 in glioma cells seems likely to foster HR-dependent DNA repair processes. The gene discussed is BRCA2; the disease is central nervous system cancer.